Sort   by:  
 Page size 
UnknownEffects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank.
Not available
S-EPMC10027475 | biostudies-literature
UnknownHuman genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetes.
Not available
S-EPMC9668288 | biostudies-literature
UnknownComparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis.
Not available
S-EPMC11906367 | biostudies-literature
UnknownRare variant contribution to human disease in 281,104 UK Biobank exomes.
Not available
S-EPMC8458098 | biostudies-literature
UnknownRare variant associations with plasma protein levels in the UK Biobank.
Not available
S-EPMC10567546 | biostudies-literature
UnknownGenetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences.
Not available
S-EPMC11387196 | biostudies-literature
UnknownProtein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease.
Not available
S-EPMC11018524 | biostudies-literature
UnknownWhole-genome sequencing of 490,640 UK Biobank participants.
Not available
S-EPMC12443626 | biostudies-literature
UnknownExome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.
Not available
S-EPMC11646479 | biostudies-literature
UnknownDe Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
Not available
S-EPMC5065681 | biostudies-literature
Sort   by:  
 Page size